Open access

Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer
Tessa S Groen-van Schooten, Rosalia Franco Fernandez, Nicole C T van Grieken, Emma N Bos, Jens Seidel, Job Saris, Carolina Martínez-Ciarpaglini, Tania C Fleitas, Daniela S Thommen, Tanja D de Gruijl, Joep Grootjans, Sarah Derks

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e009243; DOI: 10.1136/jitc-2024-009243
Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma
Sushma Bharadwaj, Eric Lau, Mark P Hamilton, Anmol Goyal, Hrishi Srinagesh, Alexandria Jensen, Dasom Lee, Jayasindhu Mallampet, Sarah Elkordy, Shriya Syal, Sunita Patil, Theresa Latchford, Bita Sahaf, Sally Arai, Laura J Johnston, Robert Lowsky, Robert Negrin, Andrew R Rezvani, Judith Shizuru, Everett H Meyer, Parveen Shiraz, Lekha Mikkilineni, Wen-Kai Weng, Melody Smith, Surbhi Sidana, Lori Muffly, Holden T Maecker, Matthew J Frank, Crystal Mackall, David Miklos, Saurabh Dahiya

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008975; DOI: 10.1136/jitc-2024-008975
Tethered IL15-IL15Rα augments antitumor activity of CD19 CAR-T cells but displays long-term toxicity in an immunocompetent lymphoma mouse model
Inés Sánchez-Moreno, Aritz Lasarte-Cia, Celia Martín-Otal, Noelia Casares, Flor Navarro, Marta Gorraiz, Patricia Sarrión, Sandra Hervas-Stubbs, Lorea Jordana, Juan Roberto Rodriguez-Madoz, Jesús San Miguel, Felipe Prosper, Juan Jose Lasarte, Teresa Lozano

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008572; DOI: 10.1136/jitc-2023-008572
Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization
William Becker, Purevdorj B Olkhanud, Noriko Seishima, Paloma A Moreno, Katherine C Goldfarbmuren, Hoyoung M Maeng, Jay A Berzofsky

Journal for ImmunoTherapy of Cancer Jul 2024, 12 (7) e008970; DOI: 10.1136/jitc-2024-008970
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells
Megen C Wittling, Hannah M Knochelmann, Megan M Wyatt, Guillermo O Rangel Rivera, Anna C Cole, Gregory B Lesinski, Chrystal M Paulos

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008715; DOI: 10.1136/jitc-2023-008715
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Jessica S W Borgers, Tineke J van Wesemael, Kyra A Gelderman, Theo Rispens, Els M E Verdegaal, Dirk J A R Moes, Catharina M Korse, Ellen Kapiteijn, Marij J P Welters, Sjoerd H van der Burg, Winan J van Houdt, Johannes V van Thienen, John B A G Haanen, Diane van der Woude

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e009215; DOI: 10.1136/jitc-2024-009215
Tumor cell-released autophagosomes (TRAPs) induce PD-L1-decorated NETs that suppress T-cell function to promote breast cancer pulmonary metastasis
Xiaohe Zhou, Chengdong Wu, Xuru Wang, Ning Pan, Xiaotong Sun, Bohao Chen, Shiya Zheng, Yiting Wei, Jing Chen, Yuyang Wu, Fengjiao Zhu, Jinpeng Chen, Huabiao Chen, Li-xin Wang

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e009082; DOI: 10.1136/jitc-2024-009082
Fc–Fc interactions and immune inhibitory effects of IgG4: implications for anti-PD-1 immunotherapies
Weifeng Zhang, Xueling Chen, Xingxing Chen, Jirui Li, Hui Wang, Xiaomiao Yan, Han Zha, Xiaonan Ma, Chanyuan Zhao, Meng Su, Liangli Hong, Penghao Li, Yanyu Ling, Wenhui Zhao, Yu Xia, Baiyong Li, Tianjing Zheng, Jiang Gu

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e009034; DOI: 10.1136/jitc-2024-009034
Expression of VISTA regulated via IFN-γ governs endogenous T-cell function and exhibits correlation with the efficacy of CD19 CAR-T cell treated B-malignant mice
Donghai Tang, Li Zhao, Fen Yan, Chunxiao Ren, Kailin Xu, Kai Zhao

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008364; DOI: 10.1136/jitc-2023-008364
Correlation of K^trans derived from dynamic contrast-enhanced MRI with treatment response and survival in locally advanced NSCLC patients undergoing induction immunochemotherapy and concurrent chemoradiotherapy
DaQuan Wang, SongRan Liu, Jia Fu, PengXin Zhang, ShiYang Zheng, Bo Qiu, Hui Liu, YongQuan Ye, JinYu Guo, Yin Zhou, HaiHang Jiang, ShaoHan Yin, HaoQiang He, ChuanMiao Xie, Hui Liu

Journal for ImmunoTherapy of Cancer Jun 2024, 12 (6) e008574; DOI: 10.1136/jitc-2023-008574

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages